Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?

Moreau, Caroline; Danel, Veronique; Devedjian, Jean Christophe; Grolez, Guillaume; Timmerman, Kelly; Laloux, Charlotte; Petrault, Maud; Gouel, Flore; Jonneaux, Aurelie; Dutheil, Mary; Lachaud, Cedrick; Lopes, Renaud; Kuchcinski, Gregory; Auger, Florent; Kyheng, Maeva; Duhamel, Alain; Perez, Thierry; Pradat, Pierre Francois; Blasco, Helene; Veyrat-Durebex, Charlotte; Corcia, Philippe; Oeckl, Patrick; Otto, Markus; Dupuis, Luc; Garcon, Guillaume; Defebvre, Luc; Cabantchik, Z. Ioav; Duce, James; Bordet, Regis; Devos, David

Erstveröffentlichung

2018

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Moreau, Caroline

Danel, Veronique

Devedjian, Jean Christophe

Grolez, Guillaume

Timmerman, Kelly

et al.

Institutions

UKU. Klinik für Neurologie
Univ Ulm, Zentrum für Biomedizinische Forschung Ulm

Published in

Antioxidants and Redox Signaling ; 29 (2018), 8. - S. 742-748. - ISSN 1523-0864. - eISSN 1557-7716

Link to publication

https://dx.doi.org/10.1089/ars.2017.7493

Funding information

Lille University Medical Center
ARSLA charity (Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres maladies du motoneurones)
ApoPharma, Inc.
Federation de la Recherche Clinique du CHU de Lille (Lille, France)

Keywords

amyotrophic lateral sclerosis; conservative iron chelator; oxidative stress; neuroprotection; treatment; disease

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record